1

Inhibition   of Cyclin D1 by Novel Biguanide Derivative YB-004 Increases the Sensitivity   of Bladder Cancer to Olaparib via Causing G0 / G1 Arrest

Int J   Biol Sci，2025，21(5):1984-1998.

杨小平

2

Synergistic   augmentation of osimertinib-induced autophagic death by proguanil or   rapamycin in bladder cancer

MedComm，2023，4(3):e236

杨小平

3

Targeted   therapies in bladder cancer: signaling pathways, applications, and challenges

MedComm，2023，4(6):e455

杨小平

4

A novel   biguanide-derivative promotes NEDD4-mediated FGFR1 ubiquitination through   BMI1 to overcome osimertinib resistance in NSCLC

Cancer   Biol Med，22(11):1381-1404.

杨小平

5

Patient-Derived   Xenograft Models: Current Status, Challenges, and Innovations in Cancer   Research

Genes Dis.2025 Jan 8;12(5):101520.

杨小平

6

Novel   combination therapy with phenformin enhances the effects of lenvatinib in   hepatocellular carcinoma via AMPK-mediated PDGFRβ degradation

Cancer Cell International 25, 361 (2025)

李朵，杨小平

7

Icariin targets PDE5A to regulate viability,   DNA synthesis and DNA damage of spermatogonial stem cells and improves   reproductive capacity

Asian   Journal of Andrology (2025)

杨小平

8

Molecular Mechanisms of Vitexin: An Update on Its Anti-Cancer Functions

Int. J.   Mol. Sci. 2025, 26, 5853

邹辉

9

The role of PRMT1 in cellular regulation and disease: Insights into   biochemical functions and emerging inhibitors for cancer therapy

Eur J Pharm Sci. 2025, 204:106958

邹辉

10

Anemarchalconyn,   a natural alkyne ketone compound, inhibits HCC cell growth by suppressing   Polθ and inducing synthetic lethality in Homologous recombination deficiency   cells

Phytomedicine   141 (2025) 156679

李俊男，邹辉

11

Natural   Tremella Polysaccharide Mitigates DEHP-Induced Oxidative Stress and Apoptosis   via Dual Regulation of Survival and Antioxidant Pathways

Foods   2025, 14, 3765

李俊男，邹辉

12

Prognostic   model for lung adenocarcinoma based on experimental drug-resistant cell lines   and clinical patients

Frontiers   in Molecular Biosciences，2025 Nov   21:12:1654426.

李俊男，胡立庆，邹辉

13

Discovery   of Artesunate (ARS) PROTACs as GPX4 protein degraders for the
  treatment of bladder cancer

European   Journal of Medicinal Chemistry 293 (2025) 117710

许藏藏

14

Inhibition   of breast cancer growth with AN-329, a novel Hsp110 inhibitor, by   inactivating p-STAT3/c-Myc axis

Biomedicine   ＆ Pharmacotherapy 2024, 181:117694

胡立庆

15

Exploration   of small-molecule inhibitors targeting Hsp110 as novel therapeutics.

Drug   Discovery Today 2025: 30(1):104287.

胡立庆

16

Design   and Optimization of LOXL2 and sGC Dual-Target Regulators Targeting   Extracellular Matrix Dysregulation and Vasodilation for the Treatment of   Pulmonary Arterial Hypertension

Journal   of Medicinal Chemistry 2025

胡立庆

17

A novel   pyridine-2-one AMPK inhibitor: Discovery, mechanism, and in vivo evaluation   in a hypoxic pulmonary arterial hypertension rat model

European   Journal of Medicinal Chemistry 2024, 279:116855.

胡立庆

18

Design,   synthesis and optimization of Apcin analogues as Cdc20 inhibitors for   triple-negative breast cancer therapy

European   Journal of Medicinal Chemistry 2025, 289:117434

胡立庆

19

Discovery   of Cdc20/Hsp90 Dual-Target Inhibitors with Potent Antitumor Activity for   Therapy of Acquired Resistant Melanoma

Journal   of Medicinal Chemistry 2025, 68(21):22428-22454.

胡立庆

20

From   fathers to offspring: epigenetic impacts of diet and lifestyle on fetal   development

Epigenetics   Insights2025, 18:e005

李健

21

Comparison   study of the correlation between free
  and total 25(OH)D in maternal and umbilical blood
  and early-life physical development parameters

J Pediatr   Endocrinol Metab 2025; aop

李健

22

Emerging   roles and therapeutic potential of tRNA-Derived small RNAs in reproductive   system diseases: a review

Front.   Cell Dev. Biol., 03 December 2025

李健

23

Identification   of CDK1 as a Biomarker for the Treatment of Liver Fibrosis and Hepatocellular   Carcinoma Through Bioinformatics Analysis

Int J Mol   Sci. 2025, 26(8):3816.

李专

24

SIRT7-mediated   NRF2 deacetylation promotes antioxidant response and protects against   chemodrug-induced liver injury

Cell   Death Dis. 2025, 16(1):232.

李专

25

Sirtuin 7   Promotes Alcohol-Associated Liver Injury via Modulating Myeloid Cell   Chemokine (C-C Motif) Ligand 2 Secretion through the NF-κB Signaling Pathway

Am J   Pathol. 2025, 195(3):575-588.

李专

26

Killing   of colistin-resistant Aeromonas hydrophila by a synthetic peptide

Microbiology   Spectrum，2025 Oct 7;13(10)

孙磊晟

27

D-M159   Synergistically Induces Apoptosis in HeLa Cells Through Endoplasmic Reticulum   Stress and Mitochondrial Dysfunction

International   Journal of Molecular Sciences 2025 Mar 29;26(7):3172.

孙磊晟

28

The   Antimicrobial Peptide D-CONGA-Q7 Eradicates Drug-Resistant E. coli by   Disrupting Bacterial Cell Membranes

Biology（Basal） 2025 Feb   21;14(3):226.

孙磊晟

29

Co-exposure   to low levels of DEHP, procymidone, Cd2 + , Pb2+, and 1-nitropyrene may   damage mouse ovary and uterus via Hippo pathway and circPVT1

Toxicol   Lett，2025，414: 111770.

朱勇飞

30

Short-Chain   Chlorinated Paraffins May Induce Ovarian Damage in Mice via AIM2- and   NLRP12-PANoptosome

Environ   Sci Technol，2025，59(1): 163-176.

朱勇飞

31

Combined   exposure to low levels of Pb2 + and 1-nitropyrene induces damage to the   hypothalamic-pituitary-ovarian axis in mice via the hippo pathway and   pyroptosis

Ecotoxicol   Environ Saf， 2025，302: 118588.

朱勇飞

32

Down-regulation   of YAP prevents smoking- and alcohol-induced carcinogenesis of esophageal   paracancerous tissue by promoting cellular pyroptosis

  Sci Rep，2025，15(1): 14766.

朱勇飞

33

Interferon-α   and thymosin-α1 plus tislelizumab enhance CD8+ T cell cytotoxicity toward   pancreatic ductal adenocarcinoma

iScience,   2025, 28, 113053

邓日林

34

A Novel   Brain-Targeting Nanoparticle Loaded with Biatractylolide and Its Protective   Effect on Alzheimer’s Disease.

Pharmaceuticals 2025, 18(6), 809

冯星，陶晓军

35

An   Elastase Inhibitor ShSPI from Centipede Attenuates Bleomycin-Induced   Pulmonary Fibrosis.

Toxins   2025, 17(5), 213

冯星

36

Synergistic   anti-triple negative breast cancer study with paclitaxel/ berberine   nanoparticle co-delivery system.

Journal   of Drug Delivery Science and Technology.106(2025)106835.

何纯莲

37

Preparation of polylysine nanoparticles for   oxaliplatin delivery and anti-colorectal cancer efficacy study.

Journal   of Drug Delivery Science and Technology.115(2026)107701.

何纯莲

38

Synergistic   chemotherapy and phototherapy co-delivery nanoparticle preparation and   anti-triple negative breast cancer study

RSC   advances, 2025,15(34):28298-28312

陶晓军